SCHEMBL5224728

SCHEMBL5224728

NCc1ccc(C(=O)NCCOC(=O)N(c2ccccc2Br)N2CC[CH]CC2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.39
ALDH1A1 P00352 1/20 0.39
HDAC3 O15379 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
NCOR2 Q9Y618 1/20 0.36
MCHR1 Q99705 1/20 0.35
KMT2A Q03164 1/20 0.35
SPHK2 Q9NRA0 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
NPC1 O15118 2/20 0.34
HSP90AA1 P07900 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
LOXL2 Q9Y4K0 2/20 0.34
LMNA P02545 1/20 0.34
TMEM97 Q5BJF2 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
CA2 P00918 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
F10 P00742 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5722183 0.87 HPGD (0.40) HPGDALDH1A1MCHR1KMT2ASPHK2
SCHEMBL5810881 0.75 SMN1; SMN2 (0.37) HPGDALDH1A1SPHK2NPSR1SMN1; SMN2
SCHEMBL4695511 0.75 PDCD1 (0.34) SMN1; SMN2
SCHEMBL5272930 0.73 SPHK2 (0.34) HPGDALDH1A1KMT2ASPHK2NPSR1
SCHEMBL6027738 0.73 ESRRG (0.40) MCHR1NPC1SMN1; SMN2RAB9A
SCHEMBL5273742 0.70 NAMPT (0.35) HPGDHDAC6SPHK2LMNATMEM97
SCHEMBL5276249 0.69 SMYD2 (0.33) HPGDALDH1A1SPHK2SMN1; SMN2LMNA
SCHEMBL4691523 0.69 TPSAB1 (0.36) ALDH1A1HDAC3HDAC6MCHR1KMT2A
SCHEMBL5278178 0.68 ALDH1A1 (0.35) HPGDALDH1A1SPHK2
SCHEMBL5275991 0.67 ATR (0.35) KMT2ATMEM97SIGMAR1F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1833822-A2 COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY Theravance, Inc. (US) 2007-09-19 EP disclosed
WO-2006023460-A2 COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY THERAVANCE, INC. (US) 2006-03-02 WO disclosed